Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.

Kanto T, Hayashi N, Takehara T, Katayama K, Kato M, Akiyama M, Kasahara A, Fusamoto H, Kamada T.

J Med Virol. 1996 Oct;50(2):126-34.

PMID:
8915878
2.

Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.

Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, et al.

J Med Virol. 1995 Jul;46(3):258-64.

PMID:
7561800
3.

Immunology of hepatitis B virus and hepatitis C virus infection.

Rehermann B, Nascimbeni M.

Nat Rev Immunol. 2005 Mar;5(3):215-29. Review.

PMID:
15738952
4.

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection.

Tsai JF, Margolis HS, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH.

Clin Immunol Immunopathol. 1995 Apr;75(1):39-44.

PMID:
7533684
5.

Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients.

Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakumu S.

Am J Gastroenterol. 1995 Oct;90(10):1847-52.

PMID:
7572907
6.

Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).

Madi N, Paccaud JP, Steiger G, Schifferli JA.

Clin Exp Immunol. 1991 Apr;84(1):9-15.

7.

Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.

Jepsen HH, Møller Rasmussen J, Teisner B, Schrøder L, Holmskov U, Jarlbaek L, Isager H, Svehag SE.

APMIS. 1990 Jul;98(7):637-44.

PMID:
2144431
8.

Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.

Thomsen BS, Heilmann C, Jacobsen SE, Pedersen FK, Morling N, Jakobsen BK, Svejgaard A, Nielsen H.

Arthritis Rheum. 1987 Sep;30(9):967-71.

PMID:
2959290
9.

Alteration of DNA ploidy and cell nuclearity in human hepatocellular carcinoma associated with HBV infection.

Gramantieri L, Melchiorri C, Chieco P, Gaiani S, Stecca B, Casali A, Bolondi L.

J Hepatol. 1996 Dec;25(6):848-53.

PMID:
9007712
10.

Hepatitis C virus-related liver damage is related to cold activation of complement.

Nomura H, Ogo T, Rikimaru N, Ueno S, Kakuno T, Okamoto O, Shiraishi G, Kashiwagi S.

J Clin Gastroenterol. 1997 Oct;25(3):529-34.

PMID:
9412971
11.

[Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].

Pascual M, Schifferli JA.

Schweiz Med Wochenschr. 1993 Jan 23;123(3):39-43. French.

PMID:
8426946
13.

Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.

Craig ML, Bankovich AJ, McElhenny JL, Taylor RP.

Arthritis Rheum. 2000 Oct;43(10):2265-75.

14.

Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.

Miyaike J, Iwasaki Y, Takahashi A, Shimomura H, Taniguchi H, Koide N, Matsuura K, Ogura T, Tobe K, Tsuji T.

Gut. 2002 Oct;51(4):591-6.

16.
17.

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.

Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F.

J Med Virol. 2001 Jul;64(3):350-5.

PMID:
11424125
18.

Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.

Madi N, Paccaud JP, Steiger G, Schifferli JA.

Clin Exp Immunol. 1989 Nov;78(2):201-6.

19.

Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.

Munson LG, Scott ME, Landay AL, Spear GT.

Clin Immunol Immunopathol. 1995 Apr;75(1):20-5.

PMID:
7533682
20.

Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.

Thomsen BS, Nielsen H, Andersen V.

Scand J Rheumatol. 1987;16(5):339-46.

PMID:
2961056

Supplemental Content

Support Center